Publicaties

​

Hostenbach S, D'Haeseleer M, Kooijman R, De Keyser J. Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis. Front Pharmacol. 2020 Jan 8;10:1491. doi: 10.3389/fphar.2019.01491.

​

Hostenbach  S,  Raeymaekers  H, Van Schuerbeek  P, Vanbinst  AM, Cools  W, De Keyser  J, D’Haeseleer M. The role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS) trial in multiple sclerosis: more questions than answers. Accepted in Frontiers in Neurology 2020 | doi: 10.3389/fneur.2020.00674.

 

Hostenbach S, Pauwels A, Michiels V, Raeymaekers H, Van Binst AM, Van Merhaeghen-Wieleman A, Van Schuerbeek P, De Keyser J, D'Haeseleer M. Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan. Trials. 2019 Mar 14;20(1):164. doi: 10.1186/s13063-019-3252-4.

 

Hostenbach S, D'Haeseleer M, Kooijman R, De Keyser J. The pathophysiological role of astrocytic endothelin-1. Prog Neurobiol. 2016 Sep;144:88-102. doi: 10.1016/j.pneurobio.2016.04.009.

 

D'haeseleer M, Hostenbach S, Peeters I, Sankari SE, Nagels G, De Keyser J, D'hooghe MB. Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? J Cereb Blood Flow Metab. 2015 Sep;35(9):1406-10. doi: 10.1038/jcbfm.2015.131.

 

Hostenbach S, Cambron M, D'haeseleer M, Kooijman R, De Keyser J. Astrocyte loss and astrogliosis in neuroinflammatory disorders. Neurosci Lett. 2014 Apr 17;565:39-41. doi: 10.1016/j.neulet.2013.10.012.